FBR Capital Maintains a 'Market Perform' on athenahealth (ATHN); Stepping Out Beyond Conservative Guidance
Tweet
Share
E-mailGet Alerts ATHN Hot Sheet
Price: $9.59 --0%
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
FBR Capital maintains a 'Market Perform' on athenahealth (NASDAQ: ATHN), PT $46.
FBR analyst says, "1Q11 was a solid quarter in a seasonally weak period, and we expect athenahealth to build off of the level it has established. Many of the operating metrics being provided were sequentially weaker in 1Q11, and we would not be surprised to see marked improvement in future quarters. The company continues to sell its Clinicals and Communicator services well into the Collector base and with new clients. We believe there is the potential for greater profitability in 2011; as a result, we are providing an EPS estimate outside the company’s guided range. athenahealth is one of the most impressive growth companies in our coverage universe, and we are not surprised by the recent outperformance, but we would also note that ATHN shares appropriately reflect that upside in their current price."
"Our 2011 EPS estimate has increased $0.08 to $0.84, mainly on the EPS beat posted in 1Q11. We are raising our 2012 EPS estimate by $0.03 to $1.13. Our estimates represent 32% YOY growth in 2011 and 34% YOY growth in 2012."
For more ratings news on athenahealth click here and for the rating history of athenahealth click here.
Shares of athenahealth closed at $46.42 yesterday.
FBR analyst says, "1Q11 was a solid quarter in a seasonally weak period, and we expect athenahealth to build off of the level it has established. Many of the operating metrics being provided were sequentially weaker in 1Q11, and we would not be surprised to see marked improvement in future quarters. The company continues to sell its Clinicals and Communicator services well into the Collector base and with new clients. We believe there is the potential for greater profitability in 2011; as a result, we are providing an EPS estimate outside the company’s guided range. athenahealth is one of the most impressive growth companies in our coverage universe, and we are not surprised by the recent outperformance, but we would also note that ATHN shares appropriately reflect that upside in their current price."
"Our 2011 EPS estimate has increased $0.08 to $0.84, mainly on the EPS beat posted in 1Q11. We are raising our 2012 EPS estimate by $0.03 to $1.13. Our estimates represent 32% YOY growth in 2011 and 34% YOY growth in 2012."
For more ratings news on athenahealth click here and for the rating history of athenahealth click here.
Shares of athenahealth closed at $46.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
